Search Results

You are looking at 1 - 2 of 2 items for

  • Author: T Ozaki x
  • Refine by access: All content x
Clear All Modify Search
P Hawkins
Search for other papers by P Hawkins in
Google Scholar
PubMed
Close
,
C Steyn
Search for other papers by C Steyn in
Google Scholar
PubMed
Close
,
HH McGarrigle
Search for other papers by HH McGarrigle in
Google Scholar
PubMed
Close
,
T Saito
Search for other papers by T Saito in
Google Scholar
PubMed
Close
,
T Ozaki
Search for other papers by T Ozaki in
Google Scholar
PubMed
Close
,
LL Stratford
Search for other papers by LL Stratford in
Google Scholar
PubMed
Close
,
DE Noakes
Search for other papers by DE Noakes in
Google Scholar
PubMed
Close
, and
MA Hanson
Search for other papers by MA Hanson in
Google Scholar
PubMed
Close

The fetal hypothalamic-pituitary-adrenal (HPA) axis has numerous key roles in development. Epidemiological data have linked adverse prenatal nutrition with altered organ development and increased incidence of disease in adult life. We studied HPA axis development in resting and stimulated states in late gestation fetal sheep, following 15% reduction in maternal nutritional intake over the first 70 days of gestation (dGA). Fetuses from control (C) and nutrient-restricted (R) ewes were chronically catheterised and response profiles for ACTH and cortisol were determined at 113-116 and 125-127 dGA after administration of corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP). At 126-128 dGA cortisol profiles were also determined following ACTH administration. Basal ACTH and cortisol concentrations were not different between C and R fetuses. In R fetuses, ACTH response to CRH+AVP was significantly smaller at 113-116 dGA (P<0.01), and cortisol responses were smaller at both 113-116 dGA (P<0.01) and 125-127 dGA (P<0.0001). Cortisol response to ACTH was also smaller in R fetuses (P<0.001). We conclude that, in late gestation fetal sheep, pituitary and adrenal responsiveness is reduced following modest maternal nutrient restriction in early gestation.

Free access
G Kovalevskaya
Search for other papers by G Kovalevskaya in
Google Scholar
PubMed
Close
,
S Birken
Search for other papers by S Birken in
Google Scholar
PubMed
Close
,
T Kakuma
Search for other papers by T Kakuma in
Google Scholar
PubMed
Close
,
N Ozaki
Search for other papers by N Ozaki in
Google Scholar
PubMed
Close
,
M Sauer
Search for other papers by M Sauer in
Google Scholar
PubMed
Close
,
S Lindheim
Search for other papers by S Lindheim in
Google Scholar
PubMed
Close
,
M Cohen
Search for other papers by M Cohen in
Google Scholar
PubMed
Close
,
A Kelly
Search for other papers by A Kelly in
Google Scholar
PubMed
Close
,
J Schlatterer
Search for other papers by J Schlatterer in
Google Scholar
PubMed
Close
, and
JF O'Connor
Search for other papers by JF O'Connor in
Google Scholar
PubMed
Close

Human chorionic gonadotropin (hCG) glycoforms change as pregnancy progresses. We have developed an antibody (B152) which can measure a hyperglycosylated early pregnancy isoform of hCG. This putative hyperglycosylated form of hCG arises very early in pregnancies and is rapidly replaced by an isoform that predominates for the remainder of the pregnancy. The profiles of these hCG glycoforms are measured as a ratio of values of two immunometric assays. The profiles of these ratios differ between pregnancies which persist and those which will experience early failure. In this report, daily urine hCG isoform ratios from donor eggs (no exogenous hCG pretreatment), in vitro fertilization pregnancies were profiled and analyzed from the first day following embryo transfer (ET). Significant differences were found between continuing pregnancy and pregnancy loss throughout days 5-20 post-ET. When hCG isoform ratios were analyzed from the first day of detectable hCG, pregnancy loss could be predicted in the case of a single fetus both during the 5- to 10-day time segment (P=0.018) and the 10- to 15-day time segment (P=0.045). When single and multiple fetus pregnancies were analyzed together significance was approached in the 10- to 15-day time period (P=0.058). In a second population of pregnant women who conceived naturally, in whom urine samples were collected at approximately weekly intervals to either term birth or clinical spontaneous abortion, the ratio could discriminate between miscarriages and normal term pregnancies (P=0.043). In later pregnancy, the ratio of hCG isoforms declined more rapidly in miscarriages than in term pregnancy. Antibody B152 was produced using a choriocarcinoma-derived hCG (C5), which was hyperglycosylated at both N- and O-linked sites and was 100% nicked at position beta(47-48). Western blot analyses supported the assay results showing that early pregnancy urine does not contain nicked C5-like hCG. Also, the early pregnancy hCG appeared to be the same size as later pregnancy hCG as judged by SDS gel electrophoresis. A series of Western blot analyses and immunoassays conducted with the samples either non-reduced or reduced showed that B152 is directed to a linear epitope located in the COOH-terminal peptide region of the beta subunit. This indicated that only the O-glycan groups and not the N-linked glycans are part of the antibody epitope.

Free access